StockWatch
·
SEJAL GLASS · Q2 FY27 · THE VERDICT

Margin surge, but management's revenue claim doesn't add up

Strong EBITDA and net profit margin expansion, with order book growth and improving capacity utilization—but a material discrepancy between the transcript's claimed revenue growth and the filed result casts doubt on management credibility.

Q2 FY27 resultsSEJALLTDSejal Glass Ltd27 Oct 2026 · 6 min read
EBITDA margin

18.35%

+132 bps YoY · target met

Net profit margin

10.31%

+258 bps YoY · exceeds 9–10% guide

Order book

₹285 Cr

+₹60 Cr vs prior · execution 6–9 mo

Revenue growth claim

±33% YoY (disputed)

Transcript vs. filed result contradiction

The core tension: Margin strength, but revenue growth claim contradicted

Sejal Glass Q2 delivered on the margin front—EBITDA margin hit 18.35% (target was 18%), and net profit margin expanded 258 basis points to 10.31%, surpassing the 9–10% year-end guidance by Q2. Order book grew ₹60 crore to ₹285 crore, with India orders doubling. Capacity utilization is improving across plants. On paper, this reads as disciplined execution. The problem: management's claim on the call about revenue growth is materially contradicted by the filed result.

The transcript records CFO Chandresh Rambhia stating total income was ₹139.86 crore in Q2 FY27, representing 33.14% year-on-year growth from ₹105.04 crore in Q2 FY26. But the delivered results context provided states revenue was down 23.8% year-on-year. These two bases don't reconcile. Either the comparison baseline is different (e.g., consolidated vs. standalone), or one of the numbers is misstated. This isn't a rounding error—it's a 57-percentage-point gap that undermines credibility on the company's biggest headline metric.

Management claims vs. what holds up

Revenue ₹139.86 Cr, +33.14% YoY from ₹105.04 Cr Q2 FY26

Contradicted

Delivered result states revenue -23.8% YoY at ₹138.1 Cr

EBITDA margin 18.35%, targeting 18% full year

Supported

Delivered OPM 17.3%, EBITDA margin guidance appears met

PAT margin 10.31%, exceeding 9–10% year-end target

Supported

Delivered NPM 10.31%, exactly matches claim

Order book ₹285 Cr (₹85 Cr India + AED78 Mn UAE), up from ₹225 Cr

Supported

India doubled ₹50 → ₹85 Cr, UAE grew AED72 → 78 Mn; total exceeds prior

Taloja capacity utilization IG temper 69%, IG glass 40%

Supported

Both up from 55% and 24% respectively; improvement evident

Fire-rated glass commercial sale expected Q4 FY27

Supported

Trial run in Q3; still pre-revenue stage; timeline reasonable

What changed on this call

Order book expanded from ₹225 crore to ₹285 crore—a ₹60 crore upgrade. Within that, India orders doubled from ₹50 crore to ₹85 crore on real estate and commercial project wins in Bangalore, Hyderabad, and Mumbai. UAE order book (AED78 million, ~₹200 crore) is for hospitality, residential, and healthcare projects, with execution expected over 6–9 months. Capacity utilization is ticking upward: Taloja IG temper moved from 55% to 69%, and Erode temper from 13% to >24%, signalling available headroom for growth without fresh capex. Dubai IG capacity sits at ~90%, nearing full utilization. Fire-rated glass trials move into Q3, with commercial revenue targeted for Q4 FY27; the company expects >30% EBITDA margins on this product. Railway-grade glass is nascent—5% conversion on ₹100+ crore quarterly tenders, but L1/L2 vendor status is new. Geographic mix is 40% India, 60% UAE currently.

Q2 FY27 margin profile, %
06.8513.720.5518.35EBITDA margin10.31PAT margin17.3OPM (delivered)
EBITDA and PAT margin both beat guidance. OPM of 17.3% sits between reported margins.

Earnings quality and the profit breakdown

Net profit of ₹14.4 crore is +15% year-on-year in the delivered result (not the +77.61% YoY claimed in the transcript if those numbers are correct). The mismatch again points to a basis difference. On the earnings quality side, management attributed EBITDA margin expansion to three drivers: (1) improved COGS from product mix, particularly in UAE where the facade division contributed to margins; (2) efficiency gains and better input negotiations (₹3% cost reduction mentioned); (3) rising capacity utilization across plants. These are structural, not one-time items, and management expects margins to remain near 18% in H2 FY27 as well. Working capital, however, is a drag: the company's project-based model requires pre-purchasing coated glass from suppliers like Saint-Gobain and Asahi, with inventory tied up until project delivery. UAE business carries 25% on letter of credit, and management is extracting LC discounts to improve cycles. The company notes profits are 'plugging back' into working capital rather than deleveraging debt.

The bull-bear ledger
  • EBITDA margin +132 bps YoY, target achieved; PAT margin +258 bps, guidance exceeded

  • Order book grew ₹60 Cr; India orders doubled on real estate project wins

  • Capacity utilization improving across Taloja, Erode, Dubai; headroom for growth without capex

  • Fire-rated glass (>30% EBITDA margin) moving into trials Q3; Q4 commercialization on track

  • Revenue growth claim (33.14% YoY) contradicted by filed result (-23.8% YoY); credibility questioned

  • Working capital headwind despite profit growth; pre-inventory model and LC terms constraining cash

  • UAE 60% of revenue exposed to geopolitical tensions; input cost inflation passed to customers

  • Railway-grade glass nascent (5% bid-win ratio); fire-rated pre-revenue; ramp execution risk

Risks, ranked by how much they should concern a holder

Revenue growth credibility

High

Transcript claims 33.14% YoY growth; filed result states -23.8% YoY decline. 57 percentage-point gap is not a rounding error. Undermines trust in management's biggest headline. Requires urgent clarification.

New product ramp execution

Medium

Fire-rated glass (₹500 Cr TAM, >30% margin) and railway-grade (₹100+ Cr quarterly tenders) are both pre-revenue or nascent. Timing slips or margin misses on commercialization would disappoint guidance.

UAE geopolitical exposure

Medium

60% of revenue from UAE. Order book AED78 Mn (~₹200 Cr) dependent on ongoing hospitality/real estate projects. Input cost inflation (logistics, shipping) noted; escalation risk if conflict worsens.

Working capital constraint

Medium

Project-based model requires pre-inventory of coated glass; 25% UAE business on LC. Profits plugging back into WC rather than deleveraging debt. Free cash flow weak relative to profit growth.

Capacity underutilization in India

Low

Taloja and Erode still <70% utilized. Headroom exists for growth, but competitive bidding on real estate/railway tenders could force price discounting, diluting margins if volume doesn't offset.

How the street is reading the story

The stock popped +20.81% on day 1 post-result and held +20.03% strength by day 3, signalling the market bought the margin and order book story despite the revenue confusion. Current price of ₹868.8 sits well above the 20-, 50-, and 200-day simple moving averages, and the stock is in a bullish trend. However, from its all-time high of ₹1,036.7, the stock is down 16.2%, suggesting some pullback after the peak. Against the 52-week low, it's up a robust 128%, reflecting the company's turnaround narrative. Ownership is promoter-heavy (69.96% in Q1 FY27), with minimal foreign institutional participation (0.19% FII) and modest domestic institutional interest (4.54% DII). Recent bulk buying by Nitin Siddamsetty in late September at ₹676.68—a known market participant—suggests insider confidence, but the absence of deep institutional conviction (low FII) is notable given the margin momentum. The market is pricing growth optionality and margin durability, but the revenue growth discrepancy hasn't yet dented enthusiasm.

The verdict

Rating: HOLD (Confidence: 6/10).

Sejal Glass has delivered on margin expansion and order book growth, and the strategic initiatives (fire-rated glass, railway-grade expansion, capacity utilization upside in India) are real. The 25–40% FY27 revenue growth guidance has a credible mechanism. But the fundamental contradiction between management's stated revenue growth claim on the call and the filed result is a material credibility issue that must be resolved. Until that discrepancy is clarified—whether it's a difference in comparison basis, a misstatement, or an error—investors should approach near-term enthusiasm with caution. The business remains solid on margins and order flow, but the profit growth story is more about operating leverage and mix than revenue expansion. Watch for Q3 results to see whether fire-rated glass trials convert to commercial shipments and whether railway-grade glass tender wins accelerate. If the revenue growth mystery isn't resolved, it will weigh on institutional participation and multiple expansion.

What to watch next
  • 1 · Revenue growth basis clarification

    Management needs to explain the discrepancy between the claimed 33.14% YoY growth and the filed result's stated -23.8% YoY decline. Is it consolidated vs. standalone, or is one metric wrong? This is the single most important item for credibility recovery.

  • 2 · Fire-rated glass commercialization (Q4 FY27)

    Trial runs in Q3; commercial revenue target Q4 FY27. If the company delivers first-quarter revenue and confirms >30% EBITDA margin guidance, the specialty products ramp becomes real and validates the 15–20% FY28 target.

  • 3 · Railway-grade glass tender wins and India order book execution

    Currently 5% bid-win ratio; L1/L2 status is new. If conversion accelerates to 10%+ and India order book (₹85 Cr) executes fully by H1 FY28, India-UAE revenue split will shift and de-risk geopolitical exposure.

Sejal Glass is executing steadily on margins and order flow, not staging a step-change. The real number to track from here is Q3 fire-rated glass progress and a clear statement on the revenue growth discrepancy. Until that clears, the stock's 20%+ post-result pop is enthusiasm ahead of proof—which is fine for a near-term trader, but a holder should wait for Q3 visibility and management credibility repair.

Informational and educational content only. Not investment advice.